中国处方药
中國處方藥
중국처방약
CHINA PRESCRIPTION DRUG
2014年
8期
12-13
,共2页
郭盛锦%吴学周%方朝辉%黄至斌
郭盛錦%吳學週%方朝輝%黃至斌
곽성금%오학주%방조휘%황지빈
胰岛素%强化降糖治疗%急性冠脉综合征%高血糖%C反应蛋白
胰島素%彊化降糖治療%急性冠脈綜閤徵%高血糖%C反應蛋白
이도소%강화강당치료%급성관맥종합정%고혈당%C반응단백
Insulin intensive hypoglycemic therapy%Acute coronary syndrome%High blood sugar%C reactive protein
目的:探讨胰岛素强化降糖方案对急性冠脉综合征(ACS)伴高血糖患者C反应蛋白和心功能的影响。方法选择2011年10月~2012年12月就诊的ACS患者220例,符合ACS发生24 h内入心脏监护室,所有患者随机血浆葡萄糖>7.8 mmol/L(抽血前2 h内无进食,无静脉输注葡萄糖)。所有患者随机分至两组,每组110例,并分别采用不同的治疗方案,其中一组采用强化胰岛素治疗(强化组),另一组采用常规胰岛素治疗(常规组)。两组患者均使用相同的常规药物进行ACS的治疗。比较分析两组患者治疗前及治疗后的糖化血红蛋白HbA1c和C反应蛋白(CRP),同时对两组患者的血清N末端B型钠尿肽前体(NT-proBNP)、左心室射血分数和左心室舒张末期内径进行检测以观察患者的心功能改善情况。结果两组患者治疗后在降糖、C反应蛋白和心功能三方面均得到明显改善(P<0.05),且强化组的改善程度明显优于常规组,差异有统计学意义(P<0.05)。结论胰岛素强化降糖治疗可显著改善ACS伴高血糖患者的心功能,其机制可能与降低C反应蛋白有关。
目的:探討胰島素彊化降糖方案對急性冠脈綜閤徵(ACS)伴高血糖患者C反應蛋白和心功能的影響。方法選擇2011年10月~2012年12月就診的ACS患者220例,符閤ACS髮生24 h內入心髒鑑護室,所有患者隨機血漿葡萄糖>7.8 mmol/L(抽血前2 h內無進食,無靜脈輸註葡萄糖)。所有患者隨機分至兩組,每組110例,併分彆採用不同的治療方案,其中一組採用彊化胰島素治療(彊化組),另一組採用常規胰島素治療(常規組)。兩組患者均使用相同的常規藥物進行ACS的治療。比較分析兩組患者治療前及治療後的糖化血紅蛋白HbA1c和C反應蛋白(CRP),同時對兩組患者的血清N末耑B型鈉尿肽前體(NT-proBNP)、左心室射血分數和左心室舒張末期內徑進行檢測以觀察患者的心功能改善情況。結果兩組患者治療後在降糖、C反應蛋白和心功能三方麵均得到明顯改善(P<0.05),且彊化組的改善程度明顯優于常規組,差異有統計學意義(P<0.05)。結論胰島素彊化降糖治療可顯著改善ACS伴高血糖患者的心功能,其機製可能與降低C反應蛋白有關。
목적:탐토이도소강화강당방안대급성관맥종합정(ACS)반고혈당환자C반응단백화심공능적영향。방법선택2011년10월~2012년12월취진적ACS환자220례,부합ACS발생24 h내입심장감호실,소유환자수궤혈장포도당>7.8 mmol/L(추혈전2 h내무진식,무정맥수주포도당)。소유환자수궤분지량조,매조110례,병분별채용불동적치료방안,기중일조채용강화이도소치료(강화조),령일조채용상규이도소치료(상규조)。량조환자균사용상동적상규약물진행ACS적치료。비교분석량조환자치료전급치료후적당화혈홍단백HbA1c화C반응단백(CRP),동시대량조환자적혈청N말단B형납뇨태전체(NT-proBNP)、좌심실사혈분수화좌심실서장말기내경진행검측이관찰환자적심공능개선정황。결과량조환자치료후재강당、C반응단백화심공능삼방면균득도명현개선(P<0.05),차강화조적개선정도명현우우상규조,차이유통계학의의(P<0.05)。결론이도소강화강당치료가현저개선ACS반고혈당환자적심공능,기궤제가능여강저C반응단백유관。
Objective To investigate the hypoglycemic effect and cardiac function improvement effect of the intensive insulin hypoglycemic therapy in acute coronary syndrome(ACS) patients with hyperglycemia.Methods 220 ACS patients with hyperglycemia diagnosed and accepted into the CCU within 24 hours in our hospital from October 2011 to December 2012 were selected. Random plasma glucose of patients were>7.8 mmol/L(there were no eating and intravenous glucose infusion 2 h before blooding). All patients were randomly divided into two groups and were adopted different therapeutic methods, one group received intensive insulin hypoglycemic therapy group(110 cases), and the other group received conventional insulin treatment group(110 cases). Two groups of patients were dealt with same conventional ACS drug treatment. Glycated hemoglobin HbA1c, C reactive protein(CRP) in two groups were detected. Then compared and analyzed the indexes before and after treatment. Serum N terminal B type natriuretic peptide precursor(NT-proBNP), left ventricular ejection fraction and left ventricular end diastolic diameter were detected to estimate the improvement status of cardiac function.Results Hypoglycemic action, C reactive protein and cardiac function status in two groups were significantly improved after treatment(P<0.05), improvement extent in intensive insulin therapy group were significantly better than conventional insulin treatment group. The difference was significant(P<0.05).Conclusion Insulin intensive hypoglycemic therapy can significantly improve the cardiac function of ACS patients with hyperglycemia, and it may be associated with the decrease of C reactive protein.